Why is this important?
Half of myocardial infarctions occur in patients with no overt hyperlipidaemia, and 20% occur in the absence of any classic risk factor. 50% of people who suffer from coronary artery disease (CAD) have normal cholesterol levels indicates the need for a more specific diagnostic tool.
A New Paradigm in LDL-Subfractions, oxidation of LDL and hereditary markers in Cholesterol Control can elucidate cardiovascular risk. The anti-inflammatory or lipid-lowering effects of pharmacologic and nutritional therapies can further be elucidated with genetic polymorphisms and apo-lipoprotein markers.
In this webinar, you will learn:
- Differentiation and clinical significance of lipid markers
- Functional pathology approach to understanding biomarkers of CVD
- Genetic risk factors and markers
- Understanding a lab report
- Management options in cholesterol and cardiovascular health
Video Duration: 38:18mins
This offering provides CPD continuing professional development credits. Attendance Certification is available upon request.